data_1j9v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j9v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.3 mm -90.17 120.26 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -137.0 102.1 4.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.12 -91.6 1.39 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.9 m -109.36 84.65 1.96 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.82 -90.31 0.65 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -157.16 -67.51 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 118.845 -0.597 . . . . 0.0 112.318 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.34 -34.49 76.18 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.75 97.55 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.363 0.983 . . . . 0.0 109.087 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.25 83.47 2.17 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.094 0.958 . . . . 0.0 108.553 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -144.91 138.95 27.27 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.512 0.725 . . . . 0.0 109.555 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.3 p -89.99 80.58 6.37 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.54 0.686 . . . . 0.0 109.836 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 123.143 1.449 . . . . 0.0 107.558 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.76 120.53 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.0 102.32 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.85 -92.69 1.46 Allowed Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m -109.65 84.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.98 -90.42 0.65 Allowed Glycine 0 N--CA 1.479 1.548 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -156.97 -67.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 118.836 -0.602 . . . . 0.0 112.213 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -68.66 -34.3 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.43 97.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.433 1.015 . . . . 0.0 109.079 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.0 83.52 2.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.152 0.981 . . . . 0.0 108.637 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -143.49 139.58 29.9 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.508 0.723 . . . . 0.0 109.684 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.1 p -91.65 78.88 5.49 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.765 0.793 . . . . 0.0 109.767 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 123.154 1.454 . . . . 0.0 107.711 -179.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.37 120.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.08 102.67 4.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.09 -93.12 1.49 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -109.14 84.45 1.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.9 -90.34 0.65 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -157.02 -67.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.2 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.55 -34.32 75.63 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -88.42 96.96 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 119.39 0.995 . . . . 0.0 109.113 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 83.56 2.18 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.209 1.003 . . . . 0.0 108.5 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -143.24 137.81 29.19 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.513 0.725 . . . . 0.0 109.44 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.2 p -91.05 81.02 5.64 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.515 0.674 . . . . 0.0 109.695 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 123.178 1.466 . . . . 0.0 107.961 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -91.99 103.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.55 94.22 4.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 -90.82 1.31 Allowed Glycine 0 CA--C 1.539 1.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.818 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -115.8 85.25 2.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.6 -92.33 0.95 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -159.5 -66.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.934 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.292 0.0 OUTLIER -61.59 -38.3 87.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -92.04 98.65 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.94 79.69 1.93 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.528 0.731 . . . . 0.0 111.078 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -124.54 142.08 51.61 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.797 0.839 . . . . 0.0 108.897 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.7 p -67.81 -47.94 67.65 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 123.232 1.492 . . . . 0.0 112.136 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -92.77 103.68 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.76 93.39 4.49 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.36 -89.81 1.2 Allowed Glycine 0 N--CA 1.479 1.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.673 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -114.56 84.56 2.08 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.61 -92.37 0.95 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -159.12 -66.55 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.679 -0.677 . . . . 0.0 111.993 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -61.59 -38.34 87.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -92.18 99.57 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.84 80.67 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.536 0.735 . . . . 0.0 111.176 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -125.91 142.56 51.46 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.777 0.831 . . . . 0.0 108.802 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -68.48 -45.53 72.11 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 123.231 1.491 . . . . 0.0 112.133 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.29 103.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -109.04 93.19 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -89.8 1.2 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -116.87 84.98 2.24 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.83 -92.42 0.9 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -158.59 -67.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.914 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -62.36 -38.2 88.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -91.01 100.01 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.99 80.71 1.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.508 0.723 . . . . 0.0 110.939 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -126.21 143.08 51.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.807 0.843 . . . . 0.0 108.849 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.8 p -68.52 -45.85 71.15 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 123.273 1.511 . . . . 0.0 112.181 -179.689 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.13 103.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -108.99 93.15 4.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.98 -89.37 1.19 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.0 m -116.39 84.94 2.21 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.71 -92.34 0.89 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -158.82 -67.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.31 -38.24 88.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.078 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.17 100.05 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 80.74 1.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.5 0.72 . . . . 0.0 111.028 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -126.23 143.26 51.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.819 0.847 . . . . 0.0 108.879 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -68.48 -45.9 71.16 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.233 1.492 . . . . 0.0 112.262 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.93 102.72 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -107.46 95.08 5.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.92 -91.49 1.32 Allowed Glycine 0 N--CA 1.48 1.585 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.837 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -112.77 85.29 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.3 -93.44 1.28 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.59 -61.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.323 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -57.85 -37.35 73.74 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -97.92 95.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 79.07 1.83 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.622 0.769 . . . . 0.0 111.082 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -123.82 142.64 50.92 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.812 0.845 . . . . 0.0 109.03 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.9 p -69.25 -45.73 69.02 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 123.222 1.487 . . . . 0.0 111.999 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.8 mm -91.93 103.51 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -108.24 94.12 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.78 -89.91 1.33 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -115.38 85.81 2.34 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.24 -92.21 0.96 Allowed Glycine 0 CA--C 1.537 1.466 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -159.39 -66.85 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.211 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.0 -38.01 87.02 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.99 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.33 79.43 1.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.56 0.744 . . . . 0.0 111.233 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -124.56 140.98 52.44 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.1 p -66.56 -47.59 72.32 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 123.189 1.471 . . . . 0.0 112.122 -179.798 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.5 120.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.41 101.79 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.07 -91.71 1.33 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -108.44 85.69 2.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.52 -89.92 0.65 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -157.5 -66.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.638 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.15 -34.61 75.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.39 97.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 119.44 1.018 . . . . 0.0 109.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.98 83.52 2.17 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.222 1.009 . . . . 0.0 108.656 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -143.58 138.08 28.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.525 0.73 . . . . 0.0 109.456 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -90.4 80.15 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.539 0.685 . . . . 0.0 109.813 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 123.161 1.458 . . . . 0.0 107.713 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.17 98.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -156.11 129.59 8.28 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.99 -70.09 1.22 Allowed Glycine 0 N--CA 1.488 2.104 0 O-C-N 121.758 -0.589 . . . . 0.0 114.041 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -105.45 84.43 2.09 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.87 -97.16 0.69 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.03 -67.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.19 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.01 -25.27 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.89 99.8 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 121.748 2.067 . . . . 0.0 108.534 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -130.65 83.27 2.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p -94.06 -69.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.714 -0.616 . . . . 0.0 111.885 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.7 t -87.99 179.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.709 0.804 . . . . 0.0 112.734 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 123.013 1.387 . . . . 0.0 110.452 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -120.29 96.93 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -157.46 128.83 6.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.36 -69.36 1.4 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.726 -0.609 . . . . 0.0 113.792 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -137.5 90.3 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.066 0.546 . . . . 0.0 109.844 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.78 -97.74 0.19 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -142.69 -80.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.014 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -130.89 59.24 1.68 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.252 0.933 . . . . 0.0 110.655 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.99 86.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -109.95 76.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.826 0.85 . . . . 0.0 108.86 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -78.41 -54.73 5.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -104.66 179.6 4.22 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.895 0.855 . . . . 0.0 111.951 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 122.971 1.367 . . . . 0.0 110.409 179.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.07 109.85 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -143.49 133.31 23.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.601 0.76 . . . . 0.0 109.417 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.02 -69.79 1.31 Allowed Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.653 -0.655 . . . . 0.0 113.686 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.7 m -104.04 85.75 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.03 -95.73 0.65 Allowed Glycine 0 N--CA 1.48 1.617 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -156.63 -70.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.5 mt -81.8 -24.07 36.16 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.85 99.22 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 121.745 2.066 . . . . 0.0 108.508 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -129.8 81.47 2.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 p -86.8 -60.76 1.9 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.662 -0.648 . . . . 0.0 112.018 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 t -99.42 161.72 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.752 0.821 . . . . 0.0 111.316 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 123.139 1.447 . . . . 0.0 110.317 179.313 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.37 95.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -155.81 128.18 7.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.94 -70.56 1.0 Allowed Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.44 -0.788 . . . . 0.0 114.492 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -98.27 84.64 3.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.52 -95.58 0.73 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -159.28 -68.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -76.19 -33.19 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.01 99.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 121.398 1.908 . . . . 0.0 109.657 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -130.45 82.68 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -98.78 -83.32 0.42 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.502 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -88.95 115.82 26.79 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.343 0.974 . . . . 0.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.584 2.135 . . . . 0.0 113.848 -179.607 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.63 97.89 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -156.72 129.49 7.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.47 -69.83 1.2 Allowed Glycine 0 N--CA 1.49 2.26 0 O-C-N 121.556 -0.715 . . . . 0.0 113.87 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.7 m -74.44 -61.3 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.77 -90.81 2.12 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -150.88 -72.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.113 0.565 . . . . 0.0 109.616 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.84 -26.25 56.98 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -86.46 75.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 120.786 1.63 . . . . 0.0 112.516 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -108.48 75.5 0.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.5 p -80.52 -79.95 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.541 -0.743 . . . . 0.0 112.571 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -96.78 124.09 40.66 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.41 1.005 . . . . 0.0 110.809 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.702 2.191 . . . . 0.0 113.843 -179.681 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.86 95.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -158.52 128.61 5.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.16 -68.63 1.58 Allowed Glycine 0 N--CA 1.487 2.062 0 O-C-N 121.72 -0.612 . . . . 0.0 114.094 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 90.31 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.944 0.498 . . . . 0.0 109.674 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.73 -95.38 0.16 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -80.08 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -140.1 65.42 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.273 0.942 . . . . 0.0 109.437 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -137.09 77.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -103.81 73.42 1.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.685 0.794 . . . . 0.0 110.115 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -85.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.482 0.713 . . . . 0.0 111.581 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -86.5 167.29 14.77 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 121.869 0.842 . . . . 0.0 112.45 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 124.297 1.998 . . . . 0.0 109.903 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.15 95.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -156.34 129.1 7.8 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.32 -70.07 1.14 Allowed Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.507 -0.745 . . . . 0.0 114.476 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.8 m -97.94 85.32 3.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.06 -95.07 0.72 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -158.39 -68.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.631 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.18 -32.69 56.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.71 99.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 121.398 1.908 . . . . 0.0 109.952 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -129.44 81.91 2.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 p -97.41 -81.8 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.77 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -90.68 116.21 28.38 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.294 0.952 . . . . 0.0 110.993 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 124.64 2.162 . . . . 0.0 113.793 -179.63 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -120.11 96.35 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -158.16 129.45 6.57 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.09 -68.68 1.56 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.743 -0.598 . . . . 0.0 113.389 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -145.5 103.4 3.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.3 -95.14 0.17 Allowed Glycine 0 N--CA 1.483 1.769 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 -79.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.6 tp -133.28 58.77 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.914 0.779 . . . . 0.0 109.571 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.57 103.67 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.99 81.61 1.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -86.0 -68.0 0.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.062 0.545 . . . . 0.0 112.217 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -88.84 178.09 6.53 Favored 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 123.785 0.834 . . . . 0.0 112.708 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 124.273 1.987 . . . . 0.0 109.696 179.504 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.8 96.41 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -159.35 128.57 5.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.09 -71.14 0.88 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.549 -0.719 . . . . 0.0 114.342 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -98.02 85.12 3.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.36 -94.89 0.71 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.06 -68.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 tp -76.59 -32.7 58.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.95 99.64 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 121.364 1.893 . . . . 0.0 109.771 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.12 82.53 2.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 p -98.39 -83.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.658 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 t -88.74 115.83 26.56 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.383 0.992 . . . . 0.0 111.278 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -179.761 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.5 mm -92.4 94.71 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -160.36 135.96 8.21 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.023 0.929 . . . . 0.0 108.614 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.62 -81.09 0.12 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 115.376 0.91 . . . . 0.0 115.376 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -111.42 80.96 1.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.99 -96.56 0.66 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.05 -68.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.735 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.2 -36.08 71.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.37 103.81 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 120.694 1.588 . . . . 0.0 107.294 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.51 90.44 2.61 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 p -71.46 -54.2 11.42 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -131.03 71.09 1.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.234 0.924 . . . . 0.0 110.353 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.845 1.307 . . . . 0.0 111.846 179.981 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -90.97 104.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -133.07 82.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.16 81.38 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.68 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -98.0 -70.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.29 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 -81.49 1.15 Allowed Glycine 0 CA--C 1.542 1.733 0 C-N-CA 123.253 0.454 . . . . 0.0 112.461 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 -72.11 0.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 119.079 -0.486 . . . . 0.0 109.989 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.28 -23.47 59.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -79.49 88.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 119.856 1.207 . . . . 0.0 111.898 -179.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.7 76.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -132.86 -57.86 0.92 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.693 0.797 . . . . 0.0 111.856 -178.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.7 t -84.53 114.65 22.1 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.3 0.955 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 124.44 2.067 . . . . 0.0 111.147 -179.777 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.45 123.8 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -127.73 89.99 3.03 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.59 95.23 0.22 Allowed Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.39 -0.672 . . . . 0.0 114.703 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -110.65 -76.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.406 0.682 . . . . 0.0 110.332 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.6 -99.1 1.53 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 119.483 -0.621 . . . . 0.0 112.452 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -132.15 -68.49 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.193 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.51 -38.36 89.64 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -84.63 88.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.322 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -47.09 1.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.3 p -99.0 89.06 4.15 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.49 99.69 4.02 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 124.352 2.025 . . . . 0.0 111.021 -179.806 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.32 124.28 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.45 88.94 2.92 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.12 94.66 0.21 Allowed Glycine 0 CA--C 1.544 1.857 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -112.71 -75.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.24 -88.33 1.32 Allowed Glycine 0 N--CA 1.482 1.712 0 C-N-CA 123.116 0.388 . . . . 0.0 113.599 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -146.68 -71.6 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.39 -33.89 75.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -87.34 85.38 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.78 -46.82 2.1 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -178.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.7 p -98.75 89.55 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.87 99.56 3.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 124.395 2.045 . . . . 0.0 111.071 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.4 mm -110.53 100.23 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -153.65 122.95 6.57 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.14 0.576 . . . . 0.0 109.728 -179.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.25 110.5 0.92 Allowed Glycine 0 CA--C 1.542 1.769 0 CA-C-O 119.253 -0.748 . . . . 0.0 112.906 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -95.7 -75.35 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.891 0.476 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.19 -87.23 1.34 Allowed Glycine 0 N--CA 1.482 1.721 0 C-N-CA 123.086 0.374 . . . . 0.0 112.963 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -142.8 -73.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.644 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.68 -21.79 65.32 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -84.33 86.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.451 1.023 . . . . 0.0 109.703 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 77.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.254 12.9 t -152.49 -52.12 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.75 0.82 . . . . 0.0 111.511 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 p -128.21 -59.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.049 1.881 . . . . 0.0 111.436 -179.915 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.25 103.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.42 122.33 8.17 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 99.36 0.63 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.307 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 t -95.34 -75.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.878 0.471 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.08 -93.15 1.88 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -135.72 -68.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.109 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.07 -33.77 76.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.24 91.14 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.984 0.811 . . . . 0.0 109.813 179.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 73.76 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -156.91 -50.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.205 1.002 . . . . 0.0 110.886 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -116.12 -65.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.366 1.066 . . . . 0.0 108.259 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 124.317 2.008 . . . . 0.0 108.44 179.395 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.12 103.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -149.77 111.92 4.64 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.35 105.96 1.42 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -119.55 86.47 2.56 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.2 -90.01 0.74 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-O 120.006 -0.33 . . . . 0.0 112.311 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.35 -64.87 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.363 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.01 -41.43 87.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.84 93.8 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.0 75.54 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -158.28 -46.01 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.072 0.949 . . . . 0.0 111.942 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.1 m -131.88 -64.74 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.387 1.075 . . . . 0.0 108.56 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 124.073 1.892 . . . . 0.0 111.527 -179.96 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -105.77 103.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -145.0 93.12 2.35 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 68.36 1.66 Allowed Glycine 0 N--CA 1.489 2.177 0 CA-C-O 119.354 -0.692 . . . . 0.0 111.524 -177.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.3 t -120.86 82.21 1.88 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.44 -92.33 0.79 Allowed Glycine 0 CA--C 1.54 1.629 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.89 -57.88 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.49 -41.16 84.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -89.41 93.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.81 75.95 1.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.684 0.793 . . . . 0.0 109.18 -179.362 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 9.6 t -151.09 -70.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.927 0.891 . . . . 0.0 108.678 179.495 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.2 m -102.7 -66.12 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.976 0.91 . . . . 0.0 108.697 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 124.455 2.074 . . . . 0.0 107.64 179.157 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.87 102.73 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -144.08 92.09 2.29 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.46 68.76 1.54 Allowed Glycine 0 N--CA 1.489 2.18 0 CA-C-O 119.337 -0.702 . . . . 0.0 111.356 -177.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -121.35 84.67 2.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.89 -91.92 0.85 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.36 -57.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.16 -41.4 83.71 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.61 93.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.85 75.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.195 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 9.2 t -152.07 -68.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.884 0.874 . . . . 0.0 108.822 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.0 m -103.54 -66.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.966 0.906 . . . . 0.0 108.625 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 124.464 2.078 . . . . 0.0 107.622 179.173 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 mm -95.04 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -151.17 123.42 8.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.72 98.21 0.59 Allowed Glycine 0 N--CA 1.483 1.833 0 CA-C-O 119.409 -0.661 . . . . 0.0 112.413 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -120.27 86.77 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.08 -89.48 0.67 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.41 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.31 -66.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.505 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.78 -36.85 82.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -87.82 92.02 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.983 0.81 . . . . 0.0 108.96 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.69 74.95 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -158.06 -50.81 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.977 0.911 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.8 m -117.83 -66.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.373 1.069 . . . . 0.0 108.372 179.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.371 2.034 . . . . 0.0 108.298 179.345 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -104.83 102.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -152.78 118.4 5.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 107.25 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 CA-C-O 119.17 -0.795 . . . . 0.0 111.557 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.0 t -118.4 82.9 1.92 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.15 -90.13 0.63 Allowed Glycine 0 N--CA 1.48 1.573 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.56 -65.66 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.182 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -40.49 87.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -179.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.21 92.62 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.65 75.29 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.12 -46.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.97 0.908 . . . . 0.0 112.144 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.9 m -130.42 -66.77 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.337 1.055 . . . . 0.0 108.158 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.08 1.895 . . . . 0.0 111.596 179.924 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.34 104.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -149.84 111.54 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 106.17 1.45 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -120.16 83.36 2.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.85 -90.35 0.65 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.278 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.15 -66.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.196 -179.369 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.51 -40.74 88.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.17 93.1 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.97 75.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.389 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -158.16 -47.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.022 0.929 . . . . 0.0 111.729 -179.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.3 m -131.12 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.453 1.101 . . . . 0.0 108.507 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.008 1.861 . . . . 0.0 111.553 -179.979 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mm -103.63 102.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -151.59 119.23 6.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.455 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.4 108.23 0.91 Allowed Glycine 0 CA--C 1.543 1.783 0 CA-C-O 119.15 -0.805 . . . . 0.0 111.817 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 t -119.78 82.93 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.02 -90.25 0.62 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 119.967 -0.352 . . . . 0.0 112.226 -179.805 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -157.71 -66.78 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.813 -0.613 . . . . 0.0 112.083 -179.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.19 -40.11 88.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 -179.099 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -85.29 92.23 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.82 74.69 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.663 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.95 -47.34 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.021 0.929 . . . . 0.0 111.94 -179.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.5 m -126.55 -67.82 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.218 1.007 . . . . 0.0 108.302 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.055 1.884 . . . . 0.0 111.721 -179.809 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.7 139.7 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 124.198 0.936 . . . . 0.0 108.533 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -159.74 119.14 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.051 0.54 . . . . 0.0 109.838 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.04 85.87 0.19 Allowed Glycine 0 N--CA 1.485 1.943 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.867 179.635 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 t -118.33 84.64 2.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.277 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.17 -88.5 0.5 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.261 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.298 0.2 OUTLIER -156.92 -64.64 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.792 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.92 -30.78 56.28 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -178.711 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -84.99 90.34 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 119.998 1.272 . . . . 0.0 110.691 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.14 65.51 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.904 0.859 . . . . 0.0 110.217 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.0 m -156.01 -75.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -98.98 112.28 24.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.785 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 124.28 1.991 . . . . 0.0 111.905 -179.502 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.25 75.98 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -154.47 114.03 3.76 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.446 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.53 79.15 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.609 -179.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.9 t -116.47 85.89 2.39 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.768 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.14 -87.83 0.52 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -158.82 -62.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -72.19 -40.18 68.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.53 97.94 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 119.087 0.858 . . . . 0.0 110.408 -179.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.18 74.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.914 0.886 . . . . 0.0 109.066 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 m -140.43 -65.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -141.61 111.42 6.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 124.325 2.012 . . . . 0.0 110.486 179.675 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.0 mm -90.87 106.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -85.46 110.59 19.28 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.684 0.394 . . . . 0.0 110.981 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.18 88.37 1.33 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -154.33 78.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.22 0.608 . . . . 0.0 109.424 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.25 -99.76 0.2 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -153.23 -74.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -79.14 -20.44 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -178.896 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.96 103.2 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 121.105 1.775 . . . . 0.0 108.331 179.814 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.08 86.26 1.97 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.9 p -81.98 115.44 21.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.609 -0.682 . . . . 0.0 110.798 -179.375 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -61.44 -34.87 76.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -179.63 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.107 1.908 . . . . 0.0 112.337 179.94 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 mm -89.16 115.61 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -146.49 114.89 6.71 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.65 86.59 1.2 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 178.642 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -149.41 73.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.27 -97.84 0.18 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.47 -74.18 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.697 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.1 mt -80.08 -23.03 41.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -178.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 2.7 pp -85.38 102.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 121.535 1.97 . . . . 0.0 109.334 179.934 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.11 84.03 2.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.583 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -86.69 116.0 24.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.805 -0.559 . . . . 0.0 110.542 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.267 12.0 t -71.15 -50.66 31.05 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 122.862 1.315 . . . . 0.0 112.445 179.772 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.69 111.0 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -86.9 106.89 18.08 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.871 0.367 . . . . 0.0 110.32 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 88.71 1.41 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.057 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -154.95 81.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.94 -99.79 0.21 Allowed Glycine 0 N--CA 1.48 1.586 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -152.8 -75.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.921 0.489 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.41 -19.5 46.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 -178.761 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.72 103.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 121.128 1.785 . . . . 0.0 108.437 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.36 85.81 1.98 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 p -80.98 117.81 21.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.927 -179.28 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -63.09 -34.47 77.66 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 -179.539 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.438 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.229 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.8 111.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -85.55 108.07 17.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.41 88.48 1.32 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -154.9 80.46 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.67 -100.52 0.22 Allowed Glycine 0 N--CA 1.48 1.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.943 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.28 -75.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.983 0.513 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.3 mt -79.89 -19.87 47.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.92 103.55 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 121.204 1.82 . . . . 0.0 108.364 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.62 85.73 1.96 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -79.81 117.26 20.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.678 -0.639 . . . . 0.0 110.994 -179.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -63.15 -36.17 82.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.496 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.65 99.21 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.05 98.0 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.25 0.548 . . . . 0.0 110.92 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.97 91.11 0.87 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 178.348 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.8 p -156.11 82.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.39 -100.22 0.21 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -152.36 -74.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.947 0.499 . . . . 0.0 109.81 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.59 -18.58 47.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 -178.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.15 102.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 121.207 1.821 . . . . 0.0 108.748 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.34 90.8 1.98 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -179.489 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -67.6 141.92 56.62 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.654 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.287 14.5 t -80.2 -59.32 2.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 122.936 1.351 . . . . 0.0 109.757 179.75 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -88.75 111.58 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -141.6 113.94 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.308 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.03 87.61 1.48 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.05 179.507 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.6 p -163.22 81.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.115 -179.607 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.06 -93.34 0.12 Allowed Glycine 0 N--CA 1.481 1.67 0 O-C-N 121.63 -0.669 . . . . 0.0 111.89 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -139.33 -80.22 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.186 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.8 mt -131.41 61.08 1.65 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.33 0.968 . . . . 0.0 110.439 179.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.09 95.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.137 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.97 88.16 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.378 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -77.64 135.65 38.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.937 0.495 . . . . 0.0 111.333 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -63.01 -35.69 81.05 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 122.764 1.268 . . . . 0.0 113.554 179.449 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.98 116.77 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -143.97 113.76 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.669 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.16 92.7 1.77 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-O 119.663 -0.521 . . . . 0.0 112.329 179.869 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -161.35 79.51 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.051 0.541 . . . . 0.0 110.749 -179.473 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.34 -94.09 0.12 Allowed Glycine 0 N--CA 1.482 1.712 0 O-C-N 121.499 -0.75 . . . . 0.0 112.197 179.735 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -137.33 -80.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.154 -179.835 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.64 61.83 1.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.3 0.954 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.02 84.78 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.33 82.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.799 -179.245 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 p -84.5 124.23 31.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.27 10.8 t -64.29 -47.44 79.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 124.35 2.024 . . . . 0.0 110.465 179.742 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.83 105.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -147.5 109.32 4.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.86 109.4 1.87 Allowed Glycine 0 CA--C 1.542 1.767 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -178.945 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.6 p -130.05 83.82 2.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.27 -95.1 0.72 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.993 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -67.73 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.78 -179.644 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.67 -39.75 94.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.142 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.64 91.35 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.539 1.518 . . . . 0.0 107.781 178.992 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -10.87 7.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -177.601 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.26 10.9 t -72.1 -49.98 31.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.972 1.714 . . . . 0.0 113.6 178.819 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.4 m -142.89 96.8 2.99 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 179.425 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 124.433 2.063 . . . . 0.0 109.259 179.553 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mm -91.8 113.58 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -144.5 99.99 3.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.587 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.37 99.97 1.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -143.63 80.37 1.66 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.056 0.542 . . . . 0.0 110.303 -179.822 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.16 -95.97 0.58 Allowed Glycine 0 N--CA 1.479 1.56 0 O-C-N 122.046 -0.409 . . . . 0.0 112.199 179.47 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -154.63 -69.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.729 -179.46 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.69 -26.85 65.5 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -179.064 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.7 tp -92.07 82.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-N 120.564 1.529 . . . . 0.0 107.721 178.491 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -41.32 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.983 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.316 9.5 t -73.62 -72.6 0.25 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.885 1.22 . . . . 0.0 113.094 -179.444 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -99.36 103.58 15.4 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.504 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.769 1.271 . . . . 0.0 110.111 179.95 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm -118.85 94.11 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -157.1 103.85 2.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.58 79.53 0.71 Allowed Glycine 0 N--CA 1.486 1.968 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.39 -179.129 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -130.6 77.03 1.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.951 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.41 -95.11 0.39 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.252 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -153.49 -70.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.922 179.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.74 -22.03 56.91 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -179.034 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.31 85.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 121.044 1.747 . . . . 0.0 110.187 179.93 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.41 68.93 0.74 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.173 0.987 . . . . 0.0 110.13 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -152.76 -54.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.945 1.298 . . . . 0.0 109.2 179.742 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.2 m -130.39 117.07 19.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 123.876 1.798 . . . . 0.0 111.86 -179.871 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.43 98.92 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -156.34 105.88 2.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.11 75.02 0.85 Allowed Glycine 0 N--CA 1.486 1.977 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.703 -179.018 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.2 p -128.33 78.57 1.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.631 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.7 -93.43 0.45 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.92 -70.41 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.21 -34.48 70.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -179.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -79.46 90.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 120.925 1.693 . . . . 0.0 111.131 -179.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.18 69.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.188 0.994 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -155.19 -68.48 0.12 Allowed 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.2 m -109.44 119.35 39.2 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 124.525 2.107 . . . . 0.0 112.076 -179.547 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.31 99.08 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -156.22 105.99 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.16 74.96 0.85 Allowed Glycine 0 N--CA 1.487 2.057 0 CA-C-O 119.599 -0.556 . . . . 0.0 112.603 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -129.0 78.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.601 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -93.7 0.46 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.95 -70.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.969 -0.538 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.49 -34.62 72.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -179.046 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -79.84 90.62 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.821 1.646 . . . . 0.0 110.956 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.68 70.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.22 1.01 . . . . 0.0 109.91 179.918 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -154.24 -66.13 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.687 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -114.71 120.58 40.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.332 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 124.522 2.106 . . . . 0.0 112.23 -179.537 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.23 129.27 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -149.77 22.76 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 -178.084 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.91 92.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.887 0 CA-C-N 120.826 1.648 . . . . 0.0 113.791 179.552 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -151.91 81.69 1.27 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.064 0.545 . . . . 0.0 110.557 -179.679 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.14 -102.12 0.3 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.327 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -137.07 -77.79 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.879 -179.799 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.29 60.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.421 1.464 . . . . 0.0 109.728 179.652 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -142.39 87.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.24 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.17 75.0 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.532 0.682 . . . . 0.0 110.77 -178.875 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.298 6.6 t -145.51 -82.78 0.14 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.706 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.9 m -99.05 121.03 40.44 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.716 1.144 . . . . 0.0 108.114 179.58 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 124.027 1.87 . . . . 0.0 111.199 179.843 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.35 112.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -126.79 72.33 1.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.824 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.16 96.9 1.93 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.27 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -135.9 78.53 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.79 -96.16 0.67 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.324 179.648 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -158.42 -65.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.009 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.38 -41.39 96.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -177.766 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.26 2.3 pp -91.78 70.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 120.844 1.656 . . . . 0.0 110.971 179.721 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.79 71.53 0.91 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.889 0.876 . . . . 0.0 110.758 -179.593 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -80.56 104.95 11.44 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.523 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -90.36 95.69 10.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -178.725 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 124.277 1.989 . . . . 0.0 110.863 -179.831 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.6 mm -88.1 110.59 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.15 92.02 3.44 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.924 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.97 104.41 0.53 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.2 m -111.08 85.34 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.941 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.1 -97.18 0.71 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -159.82 -67.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.007 -179.855 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.57 -27.71 61.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -178.205 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -90.22 100.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 121.334 1.879 . . . . 0.0 107.477 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.37 83.88 2.04 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -178.865 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -142.09 83.9 1.86 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.7 p -146.05 91.63 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.853 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 123.867 1.794 . . . . 0.0 112.386 -179.253 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.3 mm -90.17 120.26 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -137.0 102.1 4.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.12 -91.6 1.39 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.9 m -109.36 84.65 1.96 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.82 -90.31 0.65 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -157.16 -67.51 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 118.845 -0.597 . . . . 0.0 112.318 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.34 -34.49 76.18 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.75 97.55 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.363 0.983 . . . . 0.0 109.087 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.25 83.47 2.17 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.094 0.958 . . . . 0.0 108.553 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -144.91 138.95 27.27 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.512 0.725 . . . . 0.0 109.555 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.3 p -89.99 80.58 6.37 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.54 0.686 . . . . 0.0 109.836 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 123.143 1.449 . . . . 0.0 107.558 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.76 120.53 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.0 102.32 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.85 -92.69 1.46 Allowed Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m -109.65 84.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.98 -90.42 0.65 Allowed Glycine 0 N--CA 1.479 1.548 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -156.97 -67.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 118.836 -0.602 . . . . 0.0 112.213 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -68.66 -34.3 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.43 97.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.433 1.015 . . . . 0.0 109.079 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.0 83.52 2.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.152 0.981 . . . . 0.0 108.637 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -143.49 139.58 29.9 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.508 0.723 . . . . 0.0 109.684 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.1 p -91.65 78.88 5.49 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.765 0.793 . . . . 0.0 109.767 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 123.154 1.454 . . . . 0.0 107.711 -179.867 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.37 120.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.08 102.67 4.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.09 -93.12 1.49 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -109.14 84.45 1.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.9 -90.34 0.65 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -157.02 -67.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.2 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.55 -34.32 75.63 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -88.42 96.96 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 119.39 0.995 . . . . 0.0 109.113 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 83.56 2.18 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.209 1.003 . . . . 0.0 108.5 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -143.24 137.81 29.19 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.513 0.725 . . . . 0.0 109.44 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.2 p -91.05 81.02 5.64 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.515 0.674 . . . . 0.0 109.695 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 123.178 1.466 . . . . 0.0 107.961 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -91.99 103.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.55 94.22 4.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 -90.82 1.31 Allowed Glycine 0 CA--C 1.539 1.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.818 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -115.8 85.25 2.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.6 -92.33 0.95 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -159.5 -66.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.934 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.292 0.0 OUTLIER -61.59 -38.3 87.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -92.04 98.65 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.94 79.69 1.93 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.528 0.731 . . . . 0.0 111.078 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -124.54 142.08 51.61 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.797 0.839 . . . . 0.0 108.897 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.7 p -67.81 -47.94 67.65 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 123.232 1.492 . . . . 0.0 112.136 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -92.77 103.68 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.76 93.39 4.49 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.36 -89.81 1.2 Allowed Glycine 0 N--CA 1.479 1.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.673 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -114.56 84.56 2.08 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.61 -92.37 0.95 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -159.12 -66.55 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.679 -0.677 . . . . 0.0 111.993 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -61.59 -38.34 87.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -92.18 99.57 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.84 80.67 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.536 0.735 . . . . 0.0 111.176 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -125.91 142.56 51.46 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.777 0.831 . . . . 0.0 108.802 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -68.48 -45.53 72.11 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 123.231 1.491 . . . . 0.0 112.133 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.29 103.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -109.04 93.19 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -89.8 1.2 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -116.87 84.98 2.24 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.83 -92.42 0.9 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -158.59 -67.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.914 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -62.36 -38.2 88.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -91.01 100.01 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.99 80.71 1.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.508 0.723 . . . . 0.0 110.939 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -126.21 143.08 51.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.807 0.843 . . . . 0.0 108.849 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.8 p -68.52 -45.85 71.15 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 123.273 1.511 . . . . 0.0 112.181 -179.689 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.13 103.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -108.99 93.15 4.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.98 -89.37 1.19 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.0 m -116.39 84.94 2.21 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.71 -92.34 0.89 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -158.82 -67.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.31 -38.24 88.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.078 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.17 100.05 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 80.74 1.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.5 0.72 . . . . 0.0 111.028 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -126.23 143.26 51.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.819 0.847 . . . . 0.0 108.879 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -68.48 -45.9 71.16 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.233 1.492 . . . . 0.0 112.262 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.93 102.72 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -107.46 95.08 5.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.92 -91.49 1.32 Allowed Glycine 0 N--CA 1.48 1.585 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.837 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -112.77 85.29 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.3 -93.44 1.28 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.59 -61.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.323 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -57.85 -37.35 73.74 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -97.92 95.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 79.07 1.83 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.622 0.769 . . . . 0.0 111.082 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -123.82 142.64 50.92 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.812 0.845 . . . . 0.0 109.03 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.9 p -69.25 -45.73 69.02 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 123.222 1.487 . . . . 0.0 111.999 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.8 mm -91.93 103.51 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -108.24 94.12 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.78 -89.91 1.33 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -115.38 85.81 2.34 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.24 -92.21 0.96 Allowed Glycine 0 CA--C 1.537 1.466 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -159.39 -66.85 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.211 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.0 -38.01 87.02 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.99 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.33 79.43 1.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.56 0.744 . . . . 0.0 111.233 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -124.56 140.98 52.44 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.1 p -66.56 -47.59 72.32 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 123.189 1.471 . . . . 0.0 112.122 -179.798 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.5 120.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.41 101.79 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.07 -91.71 1.33 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -108.44 85.69 2.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.52 -89.92 0.65 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -157.5 -66.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.638 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.15 -34.61 75.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.39 97.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 119.44 1.018 . . . . 0.0 109.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.98 83.52 2.17 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.222 1.009 . . . . 0.0 108.656 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -143.58 138.08 28.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.525 0.73 . . . . 0.0 109.456 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -90.4 80.15 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.539 0.685 . . . . 0.0 109.813 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 123.161 1.458 . . . . 0.0 107.713 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.17 98.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -156.11 129.59 8.28 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.99 -70.09 1.22 Allowed Glycine 0 N--CA 1.488 2.104 0 O-C-N 121.758 -0.589 . . . . 0.0 114.041 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -105.45 84.43 2.09 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.87 -97.16 0.69 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.03 -67.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.19 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.01 -25.27 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.89 99.8 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 121.748 2.067 . . . . 0.0 108.534 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -130.65 83.27 2.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p -94.06 -69.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.714 -0.616 . . . . 0.0 111.885 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.7 t -87.99 179.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.709 0.804 . . . . 0.0 112.734 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 123.013 1.387 . . . . 0.0 110.452 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -120.29 96.93 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -157.46 128.83 6.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.36 -69.36 1.4 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.726 -0.609 . . . . 0.0 113.792 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -137.5 90.3 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.066 0.546 . . . . 0.0 109.844 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.78 -97.74 0.19 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -142.69 -80.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.014 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -130.89 59.24 1.68 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.252 0.933 . . . . 0.0 110.655 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.99 86.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -109.95 76.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.826 0.85 . . . . 0.0 108.86 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -78.41 -54.73 5.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -104.66 179.6 4.22 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.895 0.855 . . . . 0.0 111.951 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 122.971 1.367 . . . . 0.0 110.409 179.583 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.07 109.85 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -143.49 133.31 23.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.601 0.76 . . . . 0.0 109.417 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.02 -69.79 1.31 Allowed Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.653 -0.655 . . . . 0.0 113.686 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.7 m -104.04 85.75 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.03 -95.73 0.65 Allowed Glycine 0 N--CA 1.48 1.617 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -156.63 -70.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.5 mt -81.8 -24.07 36.16 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.85 99.22 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 121.745 2.066 . . . . 0.0 108.508 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -129.8 81.47 2.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 p -86.8 -60.76 1.9 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.662 -0.648 . . . . 0.0 112.018 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 t -99.42 161.72 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.752 0.821 . . . . 0.0 111.316 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 123.139 1.447 . . . . 0.0 110.317 179.313 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.37 95.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -155.81 128.18 7.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.94 -70.56 1.0 Allowed Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.44 -0.788 . . . . 0.0 114.492 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -98.27 84.64 3.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.52 -95.58 0.73 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -159.28 -68.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -76.19 -33.19 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.01 99.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 121.398 1.908 . . . . 0.0 109.657 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -130.45 82.68 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -98.78 -83.32 0.42 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.502 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -88.95 115.82 26.79 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.343 0.974 . . . . 0.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.584 2.135 . . . . 0.0 113.848 -179.607 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.63 97.89 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -156.72 129.49 7.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.47 -69.83 1.2 Allowed Glycine 0 N--CA 1.49 2.26 0 O-C-N 121.556 -0.715 . . . . 0.0 113.87 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.7 m -74.44 -61.3 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.77 -90.81 2.12 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -150.88 -72.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.113 0.565 . . . . 0.0 109.616 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.84 -26.25 56.98 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -86.46 75.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 120.786 1.63 . . . . 0.0 112.516 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -108.48 75.5 0.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.5 p -80.52 -79.95 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.541 -0.743 . . . . 0.0 112.571 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -96.78 124.09 40.66 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.41 1.005 . . . . 0.0 110.809 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.702 2.191 . . . . 0.0 113.843 -179.681 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.86 95.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -158.52 128.61 5.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.16 -68.63 1.58 Allowed Glycine 0 N--CA 1.487 2.062 0 O-C-N 121.72 -0.612 . . . . 0.0 114.094 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 90.31 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.944 0.498 . . . . 0.0 109.674 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.73 -95.38 0.16 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -80.08 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -140.1 65.42 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.273 0.942 . . . . 0.0 109.437 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -137.09 77.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -103.81 73.42 1.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.685 0.794 . . . . 0.0 110.115 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -85.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.482 0.713 . . . . 0.0 111.581 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -86.5 167.29 14.77 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 121.869 0.842 . . . . 0.0 112.45 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 124.297 1.998 . . . . 0.0 109.903 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.15 95.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -156.34 129.1 7.8 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.32 -70.07 1.14 Allowed Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.507 -0.745 . . . . 0.0 114.476 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.8 m -97.94 85.32 3.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.06 -95.07 0.72 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -158.39 -68.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.631 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.18 -32.69 56.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.71 99.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 121.398 1.908 . . . . 0.0 109.952 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -129.44 81.91 2.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 p -97.41 -81.8 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.77 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -90.68 116.21 28.38 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.294 0.952 . . . . 0.0 110.993 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 124.64 2.162 . . . . 0.0 113.793 -179.63 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -120.11 96.35 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -158.16 129.45 6.57 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.09 -68.68 1.56 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.743 -0.598 . . . . 0.0 113.389 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -145.5 103.4 3.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.3 -95.14 0.17 Allowed Glycine 0 N--CA 1.483 1.769 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 -79.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.6 tp -133.28 58.77 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.914 0.779 . . . . 0.0 109.571 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.57 103.67 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.99 81.61 1.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -86.0 -68.0 0.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.062 0.545 . . . . 0.0 112.217 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -88.84 178.09 6.53 Favored 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 123.785 0.834 . . . . 0.0 112.708 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 124.273 1.987 . . . . 0.0 109.696 179.504 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.8 96.41 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -159.35 128.57 5.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.09 -71.14 0.88 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.549 -0.719 . . . . 0.0 114.342 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -98.02 85.12 3.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.36 -94.89 0.71 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.06 -68.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 tp -76.59 -32.7 58.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.95 99.64 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 121.364 1.893 . . . . 0.0 109.771 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.12 82.53 2.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 p -98.39 -83.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.658 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 t -88.74 115.83 26.56 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.383 0.992 . . . . 0.0 111.278 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -179.761 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.5 mm -92.4 94.71 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -160.36 135.96 8.21 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.023 0.929 . . . . 0.0 108.614 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.62 -81.09 0.12 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 115.376 0.91 . . . . 0.0 115.376 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -111.42 80.96 1.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.99 -96.56 0.66 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.05 -68.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.735 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.2 -36.08 71.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.37 103.81 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 120.694 1.588 . . . . 0.0 107.294 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.51 90.44 2.61 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 p -71.46 -54.2 11.42 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -131.03 71.09 1.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.234 0.924 . . . . 0.0 110.353 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.845 1.307 . . . . 0.0 111.846 179.981 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -90.97 104.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -133.07 82.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.16 81.38 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.68 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -98.0 -70.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.29 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 -81.49 1.15 Allowed Glycine 0 CA--C 1.542 1.733 0 C-N-CA 123.253 0.454 . . . . 0.0 112.461 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 -72.11 0.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 119.079 -0.486 . . . . 0.0 109.989 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.28 -23.47 59.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -79.49 88.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 119.856 1.207 . . . . 0.0 111.898 -179.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.7 76.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -132.86 -57.86 0.92 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.693 0.797 . . . . 0.0 111.856 -178.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.7 t -84.53 114.65 22.1 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.3 0.955 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 124.44 2.067 . . . . 0.0 111.147 -179.777 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.45 123.8 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -127.73 89.99 3.03 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.59 95.23 0.22 Allowed Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.39 -0.672 . . . . 0.0 114.703 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -110.65 -76.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.406 0.682 . . . . 0.0 110.332 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.6 -99.1 1.53 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 119.483 -0.621 . . . . 0.0 112.452 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -132.15 -68.49 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.193 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.51 -38.36 89.64 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -84.63 88.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.322 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -47.09 1.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.3 p -99.0 89.06 4.15 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.49 99.69 4.02 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 124.352 2.025 . . . . 0.0 111.021 -179.806 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.32 124.28 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.45 88.94 2.92 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.12 94.66 0.21 Allowed Glycine 0 CA--C 1.544 1.857 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -112.71 -75.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.24 -88.33 1.32 Allowed Glycine 0 N--CA 1.482 1.712 0 C-N-CA 123.116 0.388 . . . . 0.0 113.599 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -146.68 -71.6 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.39 -33.89 75.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -87.34 85.38 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.78 -46.82 2.1 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -178.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.7 p -98.75 89.55 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.87 99.56 3.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 124.395 2.045 . . . . 0.0 111.071 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.4 mm -110.53 100.23 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -153.65 122.95 6.57 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.14 0.576 . . . . 0.0 109.728 -179.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.25 110.5 0.92 Allowed Glycine 0 CA--C 1.542 1.769 0 CA-C-O 119.253 -0.748 . . . . 0.0 112.906 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -95.7 -75.35 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.891 0.476 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.19 -87.23 1.34 Allowed Glycine 0 N--CA 1.482 1.721 0 C-N-CA 123.086 0.374 . . . . 0.0 112.963 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -142.8 -73.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.644 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.68 -21.79 65.32 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -84.33 86.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.451 1.023 . . . . 0.0 109.703 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 77.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.254 12.9 t -152.49 -52.12 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.75 0.82 . . . . 0.0 111.511 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 p -128.21 -59.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.049 1.881 . . . . 0.0 111.436 -179.915 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.25 103.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.42 122.33 8.17 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 99.36 0.63 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.307 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 t -95.34 -75.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.878 0.471 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.08 -93.15 1.88 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -135.72 -68.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.109 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.07 -33.77 76.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.24 91.14 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.984 0.811 . . . . 0.0 109.813 179.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 73.76 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -156.91 -50.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.205 1.002 . . . . 0.0 110.886 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -116.12 -65.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.366 1.066 . . . . 0.0 108.259 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 124.317 2.008 . . . . 0.0 108.44 179.395 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.12 103.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -149.77 111.92 4.64 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.35 105.96 1.42 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -119.55 86.47 2.56 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.2 -90.01 0.74 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-O 120.006 -0.33 . . . . 0.0 112.311 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.35 -64.87 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.363 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.01 -41.43 87.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.84 93.8 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.0 75.54 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -158.28 -46.01 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.072 0.949 . . . . 0.0 111.942 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.1 m -131.88 -64.74 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.387 1.075 . . . . 0.0 108.56 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 124.073 1.892 . . . . 0.0 111.527 -179.96 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -105.77 103.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -145.0 93.12 2.35 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 68.36 1.66 Allowed Glycine 0 N--CA 1.489 2.177 0 CA-C-O 119.354 -0.692 . . . . 0.0 111.524 -177.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.3 t -120.86 82.21 1.88 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.44 -92.33 0.79 Allowed Glycine 0 CA--C 1.54 1.629 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.89 -57.88 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.49 -41.16 84.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -89.41 93.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.81 75.95 1.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.684 0.793 . . . . 0.0 109.18 -179.362 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 9.6 t -151.09 -70.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.927 0.891 . . . . 0.0 108.678 179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.2 m -102.7 -66.12 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.976 0.91 . . . . 0.0 108.697 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 124.455 2.074 . . . . 0.0 107.64 179.157 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.87 102.73 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -144.08 92.09 2.29 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.46 68.76 1.54 Allowed Glycine 0 N--CA 1.489 2.18 0 CA-C-O 119.337 -0.702 . . . . 0.0 111.356 -177.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -121.35 84.67 2.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.89 -91.92 0.85 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.36 -57.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.16 -41.4 83.71 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.61 93.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.85 75.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.195 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 9.2 t -152.07 -68.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.884 0.874 . . . . 0.0 108.822 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.0 m -103.54 -66.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.966 0.906 . . . . 0.0 108.625 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 124.464 2.078 . . . . 0.0 107.622 179.173 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 mm -95.04 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -151.17 123.42 8.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.72 98.21 0.59 Allowed Glycine 0 N--CA 1.483 1.833 0 CA-C-O 119.409 -0.661 . . . . 0.0 112.413 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -120.27 86.77 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.08 -89.48 0.67 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.41 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.31 -66.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.505 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.78 -36.85 82.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -87.82 92.02 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.983 0.81 . . . . 0.0 108.96 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.69 74.95 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -158.06 -50.81 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.977 0.911 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.8 m -117.83 -66.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.373 1.069 . . . . 0.0 108.372 179.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.371 2.034 . . . . 0.0 108.298 179.345 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -104.83 102.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -152.78 118.4 5.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 107.25 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 CA-C-O 119.17 -0.795 . . . . 0.0 111.557 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.0 t -118.4 82.9 1.92 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.15 -90.13 0.63 Allowed Glycine 0 N--CA 1.48 1.573 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.56 -65.66 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.182 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -40.49 87.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -179.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.21 92.62 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.65 75.29 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.12 -46.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.97 0.908 . . . . 0.0 112.144 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.9 m -130.42 -66.77 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.337 1.055 . . . . 0.0 108.158 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.08 1.895 . . . . 0.0 111.596 179.924 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.34 104.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -149.84 111.54 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 106.17 1.45 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -120.16 83.36 2.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.85 -90.35 0.65 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.278 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.15 -66.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.196 -179.369 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.51 -40.74 88.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.17 93.1 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.97 75.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.389 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -158.16 -47.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.022 0.929 . . . . 0.0 111.729 -179.577 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.3 m -131.12 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.453 1.101 . . . . 0.0 108.507 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.008 1.861 . . . . 0.0 111.553 -179.979 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mm -103.63 102.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -151.59 119.23 6.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.455 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.4 108.23 0.91 Allowed Glycine 0 CA--C 1.543 1.783 0 CA-C-O 119.15 -0.805 . . . . 0.0 111.817 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 t -119.78 82.93 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.355 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.02 -90.25 0.62 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 119.967 -0.352 . . . . 0.0 112.226 -179.805 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -157.71 -66.78 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.813 -0.613 . . . . 0.0 112.083 -179.448 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.19 -40.11 88.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 -179.099 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -85.29 92.23 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.82 74.69 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.663 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.95 -47.34 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.021 0.929 . . . . 0.0 111.94 -179.544 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.5 m -126.55 -67.82 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.218 1.007 . . . . 0.0 108.302 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.055 1.884 . . . . 0.0 111.721 -179.809 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.7 139.7 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 124.198 0.936 . . . . 0.0 108.533 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -159.74 119.14 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.051 0.54 . . . . 0.0 109.838 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.04 85.87 0.19 Allowed Glycine 0 N--CA 1.485 1.943 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.867 179.635 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 t -118.33 84.64 2.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.277 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.17 -88.5 0.5 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.261 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.298 0.2 OUTLIER -156.92 -64.64 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.792 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.92 -30.78 56.28 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -178.711 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -84.99 90.34 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 119.998 1.272 . . . . 0.0 110.691 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.14 65.51 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.904 0.859 . . . . 0.0 110.217 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.0 m -156.01 -75.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -98.98 112.28 24.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.785 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 124.28 1.991 . . . . 0.0 111.905 -179.502 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.25 75.98 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -154.47 114.03 3.76 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.446 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.53 79.15 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.609 -179.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.9 t -116.47 85.89 2.39 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.768 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.14 -87.83 0.52 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.162 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -158.82 -62.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -72.19 -40.18 68.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.854 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.53 97.94 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 119.087 0.858 . . . . 0.0 110.408 -179.428 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.18 74.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.914 0.886 . . . . 0.0 109.066 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 m -140.43 -65.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -141.61 111.42 6.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 124.325 2.012 . . . . 0.0 110.486 179.675 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.0 mm -90.87 106.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -85.46 110.59 19.28 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.684 0.394 . . . . 0.0 110.981 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.18 88.37 1.33 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -154.33 78.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.22 0.608 . . . . 0.0 109.424 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.25 -99.76 0.2 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -153.23 -74.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -79.14 -20.44 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -178.896 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.96 103.2 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 121.105 1.775 . . . . 0.0 108.331 179.814 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.08 86.26 1.97 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.9 p -81.98 115.44 21.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.609 -0.682 . . . . 0.0 110.798 -179.375 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -61.44 -34.87 76.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -179.63 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.107 1.908 . . . . 0.0 112.337 179.94 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 mm -89.16 115.61 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -146.49 114.89 6.71 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.65 86.59 1.2 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 178.642 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -149.41 73.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.27 -97.84 0.18 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.47 -74.18 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.697 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.1 mt -80.08 -23.03 41.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -178.18 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 10' ' ' ILE 0.256 2.7 pp -85.38 102.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 121.535 1.97 . . . . 0.0 109.334 179.934 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.11 84.03 2.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.583 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -86.69 116.0 24.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.805 -0.559 . . . . 0.0 110.542 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.267 12.0 t -71.15 -50.66 31.05 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 122.862 1.315 . . . . 0.0 112.445 179.772 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.69 111.0 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -86.9 106.89 18.08 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.871 0.367 . . . . 0.0 110.32 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 88.71 1.41 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.057 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -154.95 81.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.94 -99.79 0.21 Allowed Glycine 0 N--CA 1.48 1.586 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -152.8 -75.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.921 0.489 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.41 -19.5 46.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 -178.761 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.72 103.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 121.128 1.785 . . . . 0.0 108.437 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.36 85.81 1.98 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 p -80.98 117.81 21.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.927 -179.28 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -63.09 -34.47 77.66 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 -179.539 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.438 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.229 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.8 111.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -85.55 108.07 17.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.41 88.48 1.32 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -154.9 80.46 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.67 -100.52 0.22 Allowed Glycine 0 N--CA 1.48 1.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.943 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.28 -75.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.983 0.513 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.3 mt -79.89 -19.87 47.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.92 103.55 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 121.204 1.82 . . . . 0.0 108.364 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.62 85.73 1.96 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -79.81 117.26 20.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.678 -0.639 . . . . 0.0 110.994 -179.494 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -63.15 -36.17 82.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.496 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.65 99.21 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.05 98.0 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.25 0.548 . . . . 0.0 110.92 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.97 91.11 0.87 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 178.348 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.8 p -156.11 82.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.39 -100.22 0.21 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -152.36 -74.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.947 0.499 . . . . 0.0 109.81 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.59 -18.58 47.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 -178.879 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.15 102.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 121.207 1.821 . . . . 0.0 108.748 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.34 90.8 1.98 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -179.489 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -67.6 141.92 56.62 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.654 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.287 14.5 t -80.2 -59.32 2.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 122.936 1.351 . . . . 0.0 109.757 179.75 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -88.75 111.58 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -141.6 113.94 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.308 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.03 87.61 1.48 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.05 179.507 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.6 p -163.22 81.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.115 -179.607 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.06 -93.34 0.12 Allowed Glycine 0 N--CA 1.481 1.67 0 O-C-N 121.63 -0.669 . . . . 0.0 111.89 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -139.33 -80.22 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.186 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.8 mt -131.41 61.08 1.65 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.33 0.968 . . . . 0.0 110.439 179.814 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.09 95.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.137 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.97 88.16 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.378 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -77.64 135.65 38.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.937 0.495 . . . . 0.0 111.333 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -63.01 -35.69 81.05 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 122.764 1.268 . . . . 0.0 113.554 179.449 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.98 116.77 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -143.97 113.76 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.669 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.16 92.7 1.77 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-O 119.663 -0.521 . . . . 0.0 112.329 179.869 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -161.35 79.51 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.051 0.541 . . . . 0.0 110.749 -179.473 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.34 -94.09 0.12 Allowed Glycine 0 N--CA 1.482 1.712 0 O-C-N 121.499 -0.75 . . . . 0.0 112.197 179.735 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -137.33 -80.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.154 -179.835 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.64 61.83 1.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.3 0.954 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.02 84.78 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.33 82.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.799 -179.245 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 p -84.5 124.23 31.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.27 10.8 t -64.29 -47.44 79.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 124.35 2.024 . . . . 0.0 110.465 179.742 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.83 105.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -147.5 109.32 4.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.86 109.4 1.87 Allowed Glycine 0 CA--C 1.542 1.767 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -178.945 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.6 p -130.05 83.82 2.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.27 -95.1 0.72 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.993 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -67.73 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.78 -179.644 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.67 -39.75 94.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.142 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.64 91.35 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.539 1.518 . . . . 0.0 107.781 178.992 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -10.87 7.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -177.601 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.26 10.9 t -72.1 -49.98 31.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.972 1.714 . . . . 0.0 113.6 178.819 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.4 m -142.89 96.8 2.99 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 179.425 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 124.433 2.063 . . . . 0.0 109.259 179.553 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mm -91.8 113.58 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -144.5 99.99 3.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.587 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.37 99.97 1.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -143.63 80.37 1.66 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.056 0.542 . . . . 0.0 110.303 -179.822 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.16 -95.97 0.58 Allowed Glycine 0 N--CA 1.479 1.56 0 O-C-N 122.046 -0.409 . . . . 0.0 112.199 179.47 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -154.63 -69.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.729 -179.46 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.69 -26.85 65.5 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -179.064 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.7 tp -92.07 82.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-N 120.564 1.529 . . . . 0.0 107.721 178.491 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -41.32 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.983 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.316 9.5 t -73.62 -72.6 0.25 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.885 1.22 . . . . 0.0 113.094 -179.444 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -99.36 103.58 15.4 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.504 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.769 1.271 . . . . 0.0 110.111 179.95 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm -118.85 94.11 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -157.1 103.85 2.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.58 79.53 0.71 Allowed Glycine 0 N--CA 1.486 1.968 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.39 -179.129 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -130.6 77.03 1.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.951 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.41 -95.11 0.39 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.252 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -153.49 -70.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.922 179.831 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.74 -22.03 56.91 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -179.034 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.31 85.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 121.044 1.747 . . . . 0.0 110.187 179.93 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.41 68.93 0.74 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.173 0.987 . . . . 0.0 110.13 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -152.76 -54.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.945 1.298 . . . . 0.0 109.2 179.742 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.2 m -130.39 117.07 19.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 123.876 1.798 . . . . 0.0 111.86 -179.871 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.43 98.92 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -156.34 105.88 2.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.11 75.02 0.85 Allowed Glycine 0 N--CA 1.486 1.977 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.703 -179.018 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.2 p -128.33 78.57 1.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.631 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.7 -93.43 0.45 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.307 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.92 -70.41 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.21 -34.48 70.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -179.0 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -79.46 90.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 120.925 1.693 . . . . 0.0 111.131 -179.603 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.18 69.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.188 0.994 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -155.19 -68.48 0.12 Allowed 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.2 m -109.44 119.35 39.2 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.386 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 124.525 2.107 . . . . 0.0 112.076 -179.547 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.31 99.08 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -156.22 105.99 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.16 74.96 0.85 Allowed Glycine 0 N--CA 1.487 2.057 0 CA-C-O 119.599 -0.556 . . . . 0.0 112.603 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -129.0 78.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.601 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -93.7 0.46 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.95 -70.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.969 -0.538 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.49 -34.62 72.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -179.046 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -79.84 90.62 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.821 1.646 . . . . 0.0 110.956 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.68 70.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.22 1.01 . . . . 0.0 109.91 179.918 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -154.24 -66.13 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.687 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -114.71 120.58 40.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.332 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 124.522 2.106 . . . . 0.0 112.23 -179.537 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.23 129.27 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -149.77 22.76 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 -178.084 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.91 92.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.887 0 CA-C-N 120.826 1.648 . . . . 0.0 113.791 179.552 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -151.91 81.69 1.27 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.064 0.545 . . . . 0.0 110.557 -179.679 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.14 -102.12 0.3 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.327 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -137.07 -77.79 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.879 -179.799 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.29 60.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.421 1.464 . . . . 0.0 109.728 179.652 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -142.39 87.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.24 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.17 75.0 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.532 0.682 . . . . 0.0 110.77 -178.875 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.298 6.6 t -145.51 -82.78 0.14 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.706 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.9 m -99.05 121.03 40.44 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.716 1.144 . . . . 0.0 108.114 179.58 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 124.027 1.87 . . . . 0.0 111.199 179.843 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.35 112.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -126.79 72.33 1.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.824 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.16 96.9 1.93 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.27 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -135.9 78.53 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.733 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.79 -96.16 0.67 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.324 179.648 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -158.42 -65.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.009 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.38 -41.39 96.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -177.766 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.26 2.3 pp -91.78 70.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 120.844 1.656 . . . . 0.0 110.971 179.721 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.79 71.53 0.91 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.889 0.876 . . . . 0.0 110.758 -179.593 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -80.56 104.95 11.44 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.523 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -90.36 95.69 10.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -178.725 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 124.277 1.989 . . . . 0.0 110.863 -179.831 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.6 mm -88.1 110.59 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.15 92.02 3.44 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.924 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.97 104.41 0.53 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.2 m -111.08 85.34 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.941 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.1 -97.18 0.71 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -159.82 -67.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.007 -179.855 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.57 -27.71 61.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -178.205 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -90.22 100.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 121.334 1.879 . . . . 0.0 107.477 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.37 83.88 2.04 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -178.865 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -142.09 83.9 1.86 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.7 p -146.05 91.63 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.853 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 123.867 1.794 . . . . 0.0 112.386 -179.253 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.3 mm -90.17 120.26 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -137.0 102.1 4.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.12 -91.6 1.39 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.9 m -109.36 84.65 1.96 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.82 -90.31 0.65 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -157.16 -67.51 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 118.845 -0.597 . . . . 0.0 112.318 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.34 -34.49 76.18 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.75 97.55 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.363 0.983 . . . . 0.0 109.087 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.25 83.47 2.17 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.094 0.958 . . . . 0.0 108.553 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -144.91 138.95 27.27 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.512 0.725 . . . . 0.0 109.555 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.3 p -89.99 80.58 6.37 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.54 0.686 . . . . 0.0 109.836 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 123.143 1.449 . . . . 0.0 107.558 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.76 120.53 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.0 102.32 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.85 -92.69 1.46 Allowed Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m -109.65 84.67 1.96 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.98 -90.42 0.65 Allowed Glycine 0 N--CA 1.479 1.548 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -156.97 -67.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 118.836 -0.602 . . . . 0.0 112.213 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -68.66 -34.3 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.43 97.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.433 1.015 . . . . 0.0 109.079 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.0 83.52 2.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.152 0.981 . . . . 0.0 108.637 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -143.49 139.58 29.9 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.508 0.723 . . . . 0.0 109.684 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.1 p -91.65 78.88 5.49 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.765 0.793 . . . . 0.0 109.767 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 123.154 1.454 . . . . 0.0 107.711 -179.867 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.37 120.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.08 102.67 4.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.09 -93.12 1.49 Allowed Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -109.14 84.45 1.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.9 -90.34 0.65 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -157.02 -67.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.2 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -68.55 -34.32 75.63 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -88.42 96.96 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 119.39 0.995 . . . . 0.0 109.113 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 83.56 2.18 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.209 1.003 . . . . 0.0 108.5 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -143.24 137.81 29.19 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.513 0.725 . . . . 0.0 109.44 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.2 p -91.05 81.02 5.64 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.515 0.674 . . . . 0.0 109.695 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 123.178 1.466 . . . . 0.0 107.961 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -91.99 103.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -108.55 94.22 4.94 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 -90.82 1.31 Allowed Glycine 0 CA--C 1.539 1.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.818 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -115.8 85.25 2.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.6 -92.33 0.95 Allowed Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -159.5 -66.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.934 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.292 0.0 OUTLIER -61.59 -38.3 87.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -92.04 98.65 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.94 79.69 1.93 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.528 0.731 . . . . 0.0 111.078 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -124.54 142.08 51.61 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.797 0.839 . . . . 0.0 108.897 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.7 p -67.81 -47.94 67.65 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 123.232 1.492 . . . . 0.0 112.136 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.249 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -92.77 103.68 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.76 93.39 4.49 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.36 -89.81 1.2 Allowed Glycine 0 N--CA 1.479 1.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.673 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -114.56 84.56 2.08 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.61 -92.37 0.95 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -159.12 -66.55 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.679 -0.677 . . . . 0.0 111.993 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -61.59 -38.34 87.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -92.18 99.57 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.84 80.67 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.536 0.735 . . . . 0.0 111.176 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -125.91 142.56 51.46 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.777 0.831 . . . . 0.0 108.802 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -68.48 -45.53 72.11 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 123.231 1.491 . . . . 0.0 112.133 -179.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.29 103.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -109.04 93.19 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -89.8 1.2 Allowed Glycine 0 CA--C 1.541 1.66 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -116.87 84.98 2.24 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.83 -92.42 0.9 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -158.59 -67.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.914 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.295 0.0 OUTLIER -62.36 -38.2 88.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -91.01 100.01 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.99 80.71 1.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.508 0.723 . . . . 0.0 110.939 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -126.21 143.08 51.27 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.807 0.843 . . . . 0.0 108.849 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.8 p -68.52 -45.85 71.15 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 123.273 1.511 . . . . 0.0 112.181 -179.689 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.13 103.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -108.99 93.15 4.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.98 -89.37 1.19 Allowed Glycine 0 N--CA 1.48 1.613 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.0 m -116.39 84.94 2.21 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.71 -92.34 0.89 Allowed Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -158.82 -67.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.006 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.31 -38.24 88.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.078 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.17 100.05 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 80.74 1.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.5 0.72 . . . . 0.0 111.028 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -126.23 143.26 51.21 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.819 0.847 . . . . 0.0 108.879 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -68.48 -45.9 71.16 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.233 1.492 . . . . 0.0 112.262 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.93 102.72 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -107.46 95.08 5.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.92 -91.49 1.32 Allowed Glycine 0 N--CA 1.48 1.585 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.837 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -112.77 85.29 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.3 -93.44 1.28 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.59 -61.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.323 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -57.85 -37.35 73.74 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -97.92 95.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 79.07 1.83 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.622 0.769 . . . . 0.0 111.082 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -123.82 142.64 50.92 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.812 0.845 . . . . 0.0 109.03 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.9 p -69.25 -45.73 69.02 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 123.222 1.487 . . . . 0.0 111.999 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.8 mm -91.93 103.51 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -108.24 94.12 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.78 -89.91 1.33 Allowed Glycine 0 CA--C 1.54 1.614 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -115.38 85.81 2.34 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.24 -92.21 0.96 Allowed Glycine 0 CA--C 1.537 1.466 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -159.39 -66.85 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.211 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -62.0 -38.01 87.02 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -91.99 98.67 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.33 79.43 1.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.56 0.744 . . . . 0.0 111.233 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -124.56 140.98 52.44 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.1 p -66.56 -47.59 72.32 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 123.189 1.471 . . . . 0.0 112.122 -179.798 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.5 120.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -137.41 101.79 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.07 -91.71 1.33 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -108.44 85.69 2.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.52 -89.92 0.65 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -157.5 -66.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.638 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -69.15 -34.61 75.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.39 97.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 119.44 1.018 . . . . 0.0 109.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.98 83.52 2.17 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.222 1.009 . . . . 0.0 108.656 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -143.58 138.08 28.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.525 0.73 . . . . 0.0 109.456 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.6 p -90.4 80.15 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.539 0.685 . . . . 0.0 109.813 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 123.161 1.458 . . . . 0.0 107.713 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.17 98.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -156.11 129.59 8.28 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.99 -70.09 1.22 Allowed Glycine 0 N--CA 1.488 2.104 0 O-C-N 121.758 -0.589 . . . . 0.0 114.041 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -105.45 84.43 2.09 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.87 -97.16 0.69 Allowed Glycine 0 N--CA 1.479 1.556 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.03 -67.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.19 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.01 -25.27 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.89 99.8 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 121.748 2.067 . . . . 0.0 108.534 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -130.65 83.27 2.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p -94.06 -69.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.714 -0.616 . . . . 0.0 111.885 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.7 t -87.99 179.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.709 0.804 . . . . 0.0 112.734 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 123.013 1.387 . . . . 0.0 110.452 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -120.29 96.93 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -157.46 128.83 6.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.36 -69.36 1.4 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.726 -0.609 . . . . 0.0 113.792 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -137.5 90.3 2.5 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.066 0.546 . . . . 0.0 109.844 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.78 -97.74 0.19 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -142.69 -80.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.014 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -130.89 59.24 1.68 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.252 0.933 . . . . 0.0 110.655 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.99 86.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -109.95 76.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.826 0.85 . . . . 0.0 108.86 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -78.41 -54.73 5.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -104.66 179.6 4.22 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.895 0.855 . . . . 0.0 111.951 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 122.971 1.367 . . . . 0.0 110.409 179.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.07 109.85 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -143.49 133.31 23.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.601 0.76 . . . . 0.0 109.417 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.02 -69.79 1.31 Allowed Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.653 -0.655 . . . . 0.0 113.686 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.7 m -104.04 85.75 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.03 -95.73 0.65 Allowed Glycine 0 N--CA 1.48 1.617 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -156.63 -70.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.5 mt -81.8 -24.07 36.16 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.85 99.22 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 121.745 2.066 . . . . 0.0 108.508 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -129.8 81.47 2.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 p -86.8 -60.76 1.9 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.662 -0.648 . . . . 0.0 112.018 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 t -99.42 161.72 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.752 0.821 . . . . 0.0 111.316 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 123.139 1.447 . . . . 0.0 110.317 179.313 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.37 95.48 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -155.81 128.18 7.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.94 -70.56 1.0 Allowed Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.44 -0.788 . . . . 0.0 114.492 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -98.27 84.64 3.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.52 -95.58 0.73 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -159.28 -68.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -76.19 -33.19 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.01 99.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 121.398 1.908 . . . . 0.0 109.657 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -130.45 82.68 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -98.78 -83.32 0.42 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.502 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -88.95 115.82 26.79 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.343 0.974 . . . . 0.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.584 2.135 . . . . 0.0 113.848 -179.607 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.63 97.89 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -156.72 129.49 7.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.47 -69.83 1.2 Allowed Glycine 0 N--CA 1.49 2.26 0 O-C-N 121.556 -0.715 . . . . 0.0 113.87 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.7 m -74.44 -61.3 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.77 -90.81 2.12 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -150.88 -72.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.113 0.565 . . . . 0.0 109.616 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.84 -26.25 56.98 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -86.46 75.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 120.786 1.63 . . . . 0.0 112.516 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -108.48 75.5 0.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.5 p -80.52 -79.95 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.541 -0.743 . . . . 0.0 112.571 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -96.78 124.09 40.66 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.41 1.005 . . . . 0.0 110.809 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.702 2.191 . . . . 0.0 113.843 -179.681 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.86 95.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -158.52 128.61 5.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.16 -68.63 1.58 Allowed Glycine 0 N--CA 1.487 2.062 0 O-C-N 121.72 -0.612 . . . . 0.0 114.094 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 90.31 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.944 0.498 . . . . 0.0 109.674 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.73 -95.38 0.16 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -80.08 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -140.1 65.42 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.273 0.942 . . . . 0.0 109.437 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 pp -137.09 77.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -103.81 73.42 1.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.685 0.794 . . . . 0.0 110.115 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -85.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.482 0.713 . . . . 0.0 111.581 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -86.5 167.29 14.77 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 121.869 0.842 . . . . 0.0 112.45 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 124.297 1.998 . . . . 0.0 109.903 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.15 95.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -156.34 129.1 7.8 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.32 -70.07 1.14 Allowed Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.507 -0.745 . . . . 0.0 114.476 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.8 m -97.94 85.32 3.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.06 -95.07 0.72 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -158.39 -68.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.631 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.18 -32.69 56.27 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.71 99.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 121.398 1.908 . . . . 0.0 109.952 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -129.44 81.91 2.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.5 p -97.41 -81.8 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.77 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -90.68 116.21 28.38 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.294 0.952 . . . . 0.0 110.993 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 124.64 2.162 . . . . 0.0 113.793 -179.63 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -120.11 96.35 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -158.16 129.45 6.57 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.09 -68.68 1.56 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.743 -0.598 . . . . 0.0 113.389 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -145.5 103.4 3.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.3 -95.14 0.17 Allowed Glycine 0 N--CA 1.483 1.769 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 -79.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.6 tp -133.28 58.77 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.914 0.779 . . . . 0.0 109.571 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.57 103.67 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -124.99 81.61 1.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -86.0 -68.0 0.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.062 0.545 . . . . 0.0 112.217 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -88.84 178.09 6.53 Favored 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 123.785 0.834 . . . . 0.0 112.708 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 124.273 1.987 . . . . 0.0 109.696 179.504 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.8 96.41 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -159.35 128.57 5.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.09 -71.14 0.88 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.549 -0.719 . . . . 0.0 114.342 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -98.02 85.12 3.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.36 -94.89 0.71 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.06 -68.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 tp -76.59 -32.7 58.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.95 99.64 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 121.364 1.893 . . . . 0.0 109.771 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.12 82.53 2.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 p -98.39 -83.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.658 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 t -88.74 115.83 26.56 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.383 0.992 . . . . 0.0 111.278 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -179.761 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.5 mm -92.4 94.71 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -160.36 135.96 8.21 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.023 0.929 . . . . 0.0 108.614 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.62 -81.09 0.12 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 115.376 0.91 . . . . 0.0 115.376 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.2 m -111.42 80.96 1.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.99 -96.56 0.66 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.05 -68.66 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.735 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.2 -36.08 71.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.37 103.81 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 120.694 1.588 . . . . 0.0 107.294 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.51 90.44 2.61 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 p -71.46 -54.2 11.42 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -131.03 71.09 1.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.234 0.924 . . . . 0.0 110.353 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.845 1.307 . . . . 0.0 111.846 179.981 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.225 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -90.97 104.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -133.07 82.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.16 81.38 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.68 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 94.8 p -98.0 -70.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.29 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 -81.49 1.15 Allowed Glycine 0 CA--C 1.542 1.733 0 C-N-CA 123.253 0.454 . . . . 0.0 112.461 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 -72.11 0.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 119.079 -0.486 . . . . 0.0 109.989 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -74.28 -23.47 59.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -79.49 88.14 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 119.856 1.207 . . . . 0.0 111.898 -179.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.7 76.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -132.86 -57.86 0.92 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.693 0.797 . . . . 0.0 111.856 -178.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.7 t -84.53 114.65 22.1 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.3 0.955 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 124.44 2.067 . . . . 0.0 111.147 -179.777 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.45 123.8 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -127.73 89.99 3.03 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.59 95.23 0.22 Allowed Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.39 -0.672 . . . . 0.0 114.703 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -110.65 -76.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.406 0.682 . . . . 0.0 110.332 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.6 -99.1 1.53 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 119.483 -0.621 . . . . 0.0 112.452 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -132.15 -68.49 0.62 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.193 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.51 -38.36 89.64 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -84.63 88.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.322 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -47.09 1.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.3 p -99.0 89.06 4.15 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.49 99.69 4.02 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 124.352 2.025 . . . . 0.0 111.021 -179.806 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.4 mm -84.32 124.28 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.45 88.94 2.92 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.12 94.66 0.21 Allowed Glycine 0 CA--C 1.544 1.857 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -112.71 -75.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.24 -88.33 1.32 Allowed Glycine 0 N--CA 1.482 1.712 0 C-N-CA 123.116 0.388 . . . . 0.0 113.599 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -146.68 -71.6 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.39 -33.89 75.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -87.34 85.38 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.78 -46.82 2.1 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -178.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.7 p -98.75 89.55 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -137.87 99.56 3.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 124.395 2.045 . . . . 0.0 111.071 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.4 mm -110.53 100.23 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -153.65 122.95 6.57 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.14 0.576 . . . . 0.0 109.728 -179.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.25 110.5 0.92 Allowed Glycine 0 CA--C 1.542 1.769 0 CA-C-O 119.253 -0.748 . . . . 0.0 112.906 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -95.7 -75.35 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.891 0.476 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.19 -87.23 1.34 Allowed Glycine 0 N--CA 1.482 1.721 0 C-N-CA 123.086 0.374 . . . . 0.0 112.963 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -142.8 -73.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.644 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.68 -21.79 65.32 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -84.33 86.09 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.451 1.023 . . . . 0.0 109.703 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 77.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.254 12.9 t -152.49 -52.12 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.75 0.82 . . . . 0.0 111.511 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 p -128.21 -59.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.049 1.881 . . . . 0.0 111.436 -179.915 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.25 103.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.42 122.33 8.17 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 99.36 0.63 Allowed Glycine 0 N--CA 1.483 1.819 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.307 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 t -95.34 -75.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.878 0.471 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.08 -93.15 1.88 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -135.72 -68.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.109 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.07 -33.77 76.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.24 91.14 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.984 0.811 . . . . 0.0 109.813 179.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 73.76 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -156.91 -50.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.205 1.002 . . . . 0.0 110.886 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -116.12 -65.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.366 1.066 . . . . 0.0 108.259 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 124.317 2.008 . . . . 0.0 108.44 179.395 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.12 103.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -149.77 111.92 4.64 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.35 105.96 1.42 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 t -119.55 86.47 2.56 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.2 -90.01 0.74 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-O 120.006 -0.33 . . . . 0.0 112.311 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.35 -64.87 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.363 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.01 -41.43 87.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.84 93.8 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.0 75.54 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -158.28 -46.01 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.072 0.949 . . . . 0.0 111.942 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.1 m -131.88 -64.74 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.387 1.075 . . . . 0.0 108.56 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 124.073 1.892 . . . . 0.0 111.527 -179.96 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -105.77 103.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -145.0 93.12 2.35 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 68.36 1.66 Allowed Glycine 0 N--CA 1.489 2.177 0 CA-C-O 119.354 -0.692 . . . . 0.0 111.524 -177.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.3 t -120.86 82.21 1.88 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.44 -92.33 0.79 Allowed Glycine 0 CA--C 1.54 1.629 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.89 -57.88 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.49 -41.16 84.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -89.41 93.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.81 75.95 1.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.684 0.793 . . . . 0.0 109.18 -179.362 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 9.6 t -151.09 -70.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.927 0.891 . . . . 0.0 108.678 179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.2 m -102.7 -66.12 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.976 0.91 . . . . 0.0 108.697 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 124.455 2.074 . . . . 0.0 107.64 179.157 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.87 102.73 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -144.08 92.09 2.29 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.46 68.76 1.54 Allowed Glycine 0 N--CA 1.489 2.18 0 CA-C-O 119.337 -0.702 . . . . 0.0 111.356 -177.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.1 t -121.35 84.67 2.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.89 -91.92 0.85 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.36 -57.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.16 -41.4 83.71 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.61 93.6 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.85 75.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.195 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 9.2 t -152.07 -68.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.884 0.874 . . . . 0.0 108.822 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.0 m -103.54 -66.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.966 0.906 . . . . 0.0 108.625 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 124.464 2.078 . . . . 0.0 107.622 179.173 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.9 mm -95.04 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -151.17 123.42 8.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.72 98.21 0.59 Allowed Glycine 0 N--CA 1.483 1.833 0 CA-C-O 119.409 -0.661 . . . . 0.0 112.413 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -120.27 86.77 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.08 -89.48 0.67 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.41 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.31 -66.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.505 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.78 -36.85 82.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -87.82 92.02 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.983 0.81 . . . . 0.0 108.96 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.69 74.95 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -158.06 -50.81 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.977 0.911 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.8 m -117.83 -66.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.373 1.069 . . . . 0.0 108.372 179.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 124.371 2.034 . . . . 0.0 108.298 179.345 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -104.83 102.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -152.78 118.4 5.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 107.25 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 CA-C-O 119.17 -0.795 . . . . 0.0 111.557 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.0 t -118.4 82.9 1.92 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.15 -90.13 0.63 Allowed Glycine 0 N--CA 1.48 1.573 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.56 -65.66 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.182 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -40.49 87.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -179.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -86.21 92.62 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.65 75.29 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.12 -46.05 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.97 0.908 . . . . 0.0 112.144 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.9 m -130.42 -66.77 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.337 1.055 . . . . 0.0 108.158 179.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.08 1.895 . . . . 0.0 111.596 179.924 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.34 104.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -149.84 111.54 4.52 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 106.17 1.45 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -120.16 83.36 2.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.85 -90.35 0.65 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.278 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -158.15 -66.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 118.827 -0.606 . . . . 0.0 112.196 -179.369 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.51 -40.74 88.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.17 93.1 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.97 75.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.389 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -158.16 -47.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.022 0.929 . . . . 0.0 111.729 -179.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.3 m -131.12 -64.9 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.453 1.101 . . . . 0.0 108.507 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 124.008 1.861 . . . . 0.0 111.553 -179.979 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mm -103.63 102.33 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -151.59 119.23 6.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.455 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.4 108.23 0.91 Allowed Glycine 0 CA--C 1.543 1.783 0 CA-C-O 119.15 -0.805 . . . . 0.0 111.817 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 t -119.78 82.93 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.02 -90.25 0.62 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 119.967 -0.352 . . . . 0.0 112.226 -179.805 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -157.71 -66.78 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.813 -0.613 . . . . 0.0 112.083 -179.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.19 -40.11 88.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 -179.099 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -85.29 92.23 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.356 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.82 74.69 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.663 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -158.95 -47.34 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.021 0.929 . . . . 0.0 111.94 -179.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.5 m -126.55 -67.82 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.218 1.007 . . . . 0.0 108.302 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.055 1.884 . . . . 0.0 111.721 -179.809 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.7 139.7 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 124.198 0.936 . . . . 0.0 108.533 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -159.74 119.14 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.051 0.54 . . . . 0.0 109.838 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.04 85.87 0.19 Allowed Glycine 0 N--CA 1.485 1.943 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.867 179.635 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 t -118.33 84.64 2.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.277 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.17 -88.5 0.5 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.261 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.298 0.2 OUTLIER -156.92 -64.64 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.792 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.92 -30.78 56.28 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -178.711 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -84.99 90.34 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 119.998 1.272 . . . . 0.0 110.691 -179.387 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.14 65.51 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.904 0.859 . . . . 0.0 110.217 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.0 m -156.01 -75.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -98.98 112.28 24.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.785 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 124.28 1.991 . . . . 0.0 111.905 -179.502 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.25 75.98 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -154.47 114.03 3.76 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.446 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.53 79.15 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.609 -179.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.9 t -116.47 85.89 2.39 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.768 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.14 -87.83 0.52 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -158.82 -62.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -72.19 -40.18 68.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.854 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.53 97.94 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 119.087 0.858 . . . . 0.0 110.408 -179.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.18 74.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.914 0.886 . . . . 0.0 109.066 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 m -140.43 -65.85 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -141.61 111.42 6.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 124.325 2.012 . . . . 0.0 110.486 179.675 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.0 mm -90.87 106.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -85.46 110.59 19.28 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.684 0.394 . . . . 0.0 110.981 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.18 88.37 1.33 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -154.33 78.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.22 0.608 . . . . 0.0 109.424 179.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.25 -99.76 0.2 Allowed Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -153.23 -74.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -79.14 -20.44 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -178.896 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.96 103.2 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 121.105 1.775 . . . . 0.0 108.331 179.814 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.08 86.26 1.97 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.9 p -81.98 115.44 21.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.609 -0.682 . . . . 0.0 110.798 -179.375 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -61.44 -34.87 76.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -179.63 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.107 1.908 . . . . 0.0 112.337 179.94 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 mm -89.16 115.61 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -146.49 114.89 6.71 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.65 86.59 1.2 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 178.642 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.2 p -149.41 73.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.27 -97.84 0.18 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.47 -74.18 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.697 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.1 mt -80.08 -23.03 41.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -178.18 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 10' ' ' ILE 0.256 2.7 pp -85.38 102.18 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 121.535 1.97 . . . . 0.0 109.334 179.934 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.11 84.03 2.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.583 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -86.69 116.0 24.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.805 -0.559 . . . . 0.0 110.542 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.267 12.0 t -71.15 -50.66 31.05 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 122.862 1.315 . . . . 0.0 112.445 179.772 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.69 111.0 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -86.9 106.89 18.08 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.871 0.367 . . . . 0.0 110.32 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 88.71 1.41 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.057 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -154.95 81.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.94 -99.79 0.21 Allowed Glycine 0 N--CA 1.48 1.586 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -152.8 -75.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.921 0.489 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.41 -19.5 46.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 -178.761 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.72 103.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 121.128 1.785 . . . . 0.0 108.437 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.36 85.81 1.98 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 p -80.98 117.81 21.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.927 -179.28 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 t -63.09 -34.47 77.66 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 -179.539 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.438 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.229 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.8 111.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -85.55 108.07 17.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.858 0.361 . . . . 0.0 110.948 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.41 88.48 1.32 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -154.9 80.46 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.67 -100.52 0.22 Allowed Glycine 0 N--CA 1.48 1.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.943 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.28 -75.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.983 0.513 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.3 mt -79.89 -19.87 47.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.92 103.55 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 121.204 1.82 . . . . 0.0 108.364 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.62 85.73 1.96 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -79.81 117.26 20.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.678 -0.639 . . . . 0.0 110.994 -179.494 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -63.15 -36.17 82.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.496 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.65 99.21 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.05 98.0 7.63 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.25 0.548 . . . . 0.0 110.92 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.97 91.11 0.87 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 178.348 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.8 p -156.11 82.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 147.39 -100.22 0.21 Allowed Glycine 0 N--CA 1.481 1.697 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -152.36 -74.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.947 0.499 . . . . 0.0 109.81 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.2 mt -80.59 -18.58 47.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 -178.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -84.15 102.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 121.207 1.821 . . . . 0.0 108.748 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.34 90.8 1.98 Allowed 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -179.489 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -67.6 141.92 56.62 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.654 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.287 14.5 t -80.2 -59.32 2.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 122.936 1.351 . . . . 0.0 109.757 179.75 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mm -88.75 111.58 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -141.6 113.94 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.308 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.03 87.61 1.48 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.05 179.507 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.6 p -163.22 81.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.357 0.663 . . . . 0.0 110.115 -179.607 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.06 -93.34 0.12 Allowed Glycine 0 N--CA 1.481 1.67 0 O-C-N 121.63 -0.669 . . . . 0.0 111.89 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -139.33 -80.22 0.31 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.186 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.8 mt -131.41 61.08 1.65 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.33 0.968 . . . . 0.0 110.439 179.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.09 95.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.137 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.97 88.16 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.378 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.5 p -77.64 135.65 38.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.937 0.495 . . . . 0.0 111.333 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -63.01 -35.69 81.05 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 122.764 1.268 . . . . 0.0 113.554 179.449 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.266 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.98 116.77 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -143.97 113.76 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.669 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.16 92.7 1.77 Allowed Glycine 0 N--CA 1.482 1.702 0 CA-C-O 119.663 -0.521 . . . . 0.0 112.329 179.869 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -161.35 79.51 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.051 0.541 . . . . 0.0 110.749 -179.473 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.34 -94.09 0.12 Allowed Glycine 0 N--CA 1.482 1.712 0 O-C-N 121.499 -0.75 . . . . 0.0 112.197 179.735 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -137.33 -80.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.154 -179.835 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.64 61.83 1.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.3 0.954 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.02 84.78 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.33 82.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.799 -179.245 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 p -84.5 124.23 31.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.129 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.27 10.8 t -64.29 -47.44 79.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 124.35 2.024 . . . . 0.0 110.465 179.742 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.83 105.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -147.5 109.32 4.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.86 109.4 1.87 Allowed Glycine 0 CA--C 1.542 1.767 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -178.945 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.6 p -130.05 83.82 2.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.27 -95.1 0.72 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.993 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -67.73 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.78 -179.644 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.67 -39.75 94.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.142 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.64 91.35 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.539 1.518 . . . . 0.0 107.781 178.992 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -10.87 7.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -177.601 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.26 10.9 t -72.1 -49.98 31.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.972 1.714 . . . . 0.0 113.6 178.819 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.4 m -142.89 96.8 2.99 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 179.425 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 124.433 2.063 . . . . 0.0 109.259 179.553 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mm -91.8 113.58 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -144.5 99.99 3.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.587 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.37 99.97 1.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.353 -179.656 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -143.63 80.37 1.66 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.056 0.542 . . . . 0.0 110.303 -179.822 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.16 -95.97 0.58 Allowed Glycine 0 N--CA 1.479 1.56 0 O-C-N 122.046 -0.409 . . . . 0.0 112.199 179.47 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -154.63 -69.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.729 -179.46 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.69 -26.85 65.5 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -179.064 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.7 tp -92.07 82.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-N 120.564 1.529 . . . . 0.0 107.721 178.491 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -41.32 1.6 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.983 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.316 9.5 t -73.62 -72.6 0.25 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.885 1.22 . . . . 0.0 113.094 -179.444 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -99.36 103.58 15.4 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.504 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.769 1.271 . . . . 0.0 110.111 179.95 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm -118.85 94.11 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -157.1 103.85 2.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.58 79.53 0.71 Allowed Glycine 0 N--CA 1.486 1.968 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.39 -179.129 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -130.6 77.03 1.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.951 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.41 -95.11 0.39 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.252 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -153.49 -70.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.922 179.831 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.74 -22.03 56.91 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -179.034 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -86.31 85.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 121.044 1.747 . . . . 0.0 110.187 179.93 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.41 68.93 0.74 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.173 0.987 . . . . 0.0 110.13 -179.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -152.76 -54.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.945 1.298 . . . . 0.0 109.2 179.742 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.2 m -130.39 117.07 19.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 123.876 1.798 . . . . 0.0 111.86 -179.871 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.43 98.92 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -156.34 105.88 2.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.11 75.02 0.85 Allowed Glycine 0 N--CA 1.486 1.977 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.703 -179.018 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.2 p -128.33 78.57 1.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.631 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.7 -93.43 0.45 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.307 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.92 -70.41 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.21 -34.48 70.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -179.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -79.46 90.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 120.925 1.693 . . . . 0.0 111.131 -179.603 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.18 69.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.188 0.994 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -155.19 -68.48 0.12 Allowed 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.2 m -109.44 119.35 39.2 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 124.525 2.107 . . . . 0.0 112.076 -179.547 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.31 99.08 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -156.22 105.99 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.16 74.96 0.85 Allowed Glycine 0 N--CA 1.487 2.057 0 CA-C-O 119.599 -0.556 . . . . 0.0 112.603 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -129.0 78.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.601 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -93.7 0.46 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.95 -70.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.969 -0.538 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.49 -34.62 72.57 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -179.046 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -79.84 90.62 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.821 1.646 . . . . 0.0 110.956 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.68 70.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.22 1.01 . . . . 0.0 109.91 179.918 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -154.24 -66.13 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.687 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -114.71 120.58 40.57 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.332 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 124.522 2.106 . . . . 0.0 112.23 -179.537 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.23 129.27 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -149.77 22.76 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 -178.084 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.91 92.0 0.08 OUTLIER Glycine 0 N--CA 1.484 1.887 0 CA-C-N 120.826 1.648 . . . . 0.0 113.791 179.552 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.7 p -151.91 81.69 1.27 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.064 0.545 . . . . 0.0 110.557 -179.679 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.14 -102.12 0.3 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.327 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -137.07 -77.79 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.879 -179.799 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.29 60.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.421 1.464 . . . . 0.0 109.728 179.652 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -142.39 87.43 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.24 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.17 75.0 0.9 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.532 0.682 . . . . 0.0 110.77 -178.875 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.298 6.6 t -145.51 -82.78 0.14 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.706 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.9 m -99.05 121.03 40.44 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.716 1.144 . . . . 0.0 108.114 179.58 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 124.027 1.87 . . . . 0.0 111.199 179.843 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.35 112.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -126.79 72.33 1.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.824 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.16 96.9 1.93 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.27 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -135.9 78.53 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.733 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.79 -96.16 0.67 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.732 -0.482 . . . . 0.0 112.324 179.648 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -158.42 -65.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.009 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.38 -41.39 96.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -177.766 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.26 2.3 pp -91.78 70.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 120.844 1.656 . . . . 0.0 110.971 179.721 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.79 71.53 0.91 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.889 0.876 . . . . 0.0 110.758 -179.593 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -80.56 104.95 11.44 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.523 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -90.36 95.69 10.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -178.725 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 124.277 1.989 . . . . 0.0 110.863 -179.831 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.6 mm -88.1 110.59 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.15 92.02 3.44 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.924 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.97 104.41 0.53 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.2 m -111.08 85.34 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.941 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.1 -97.18 0.71 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -159.82 -67.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.007 -179.855 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.57 -27.71 61.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -178.205 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -90.22 100.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 121.334 1.879 . . . . 0.0 107.477 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.37 83.88 2.04 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -178.865 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -142.09 83.9 1.86 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.7 p -146.05 91.63 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.853 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 123.867 1.794 . . . . 0.0 112.386 -179.253 . . . . . . . . 0 0 . 1 stop_ save_